Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-16-009007
Filing Date
2016-04-04
Accepted
2016-04-04 18:58:15
Documents
1
Period of Report
2016-04-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_040416winquist.html 4  
1 OWNERSHIP DOCUMENT f4_040416winquist.xml 4 3987
  Complete submission text file 0001171843-16-009007.txt   5320
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A0 V5G 48W
Business Address
WINQUIST RAYMOND (Reporting) CIK: 0001670668 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 161552538